livemint.com
37%
599
GlaxoSmithKline CEO says vaccine makers staking reputations on Covid-19
Covid-19 fail, according to Emma Walmsley, chief executive officer of GlaxoSmithKline Plc.The industry’s commitment will help ensure that the shots that do make it to the market are safe after a one-year development cycle, which is a fraction of the normal time needed, the head of the world’s largest vaccine maker said.“The world will pay a very big price, not just for Covid, but beyond that if we break trust in the quality of vaccination," she said in an interview on The David Rubenstein Show: Peer-to-Peer Conversations on Bloomberg Television.The race to develop vaccines and treatments for Covid are set to permanently accelerate drug discovery, Walmsley said.